GSK-3 Inhibitors: Anti-Diabetic Treatment Associated with Cardiac Risk?

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Pages (from-to)	233-235
Journal	Cardiovascular Drugs and Therapy
Volume	30
Issue number	3
DOIs	https://doi.org/10.1007/s10557-016-6669-y
Publication status	Published - Jun 2016

Access to Document

@article{ae2523a569af40b5b9553abed54e2ef1,

title = "GSK-3 Inhibitors: Anti-Diabetic Treatment Associated with Cardiac Risk?",

author = "Miranda Nabben and Dietbert Neumann",

year = "2016",

month = jun,

doi = "10.1007/s10557-016-6669-y",

language = "English",

volume = "30",

pages = "233--235",

journal = "Cardiovascular Drugs and Therapy",

issn = "0920-3206",